Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Resectable Esophageal Cancer × Cetuximab × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 278 Colonic Neoplasms 79 Rectal Neoplasms 72 Neoplasm Metastasis 37 Pancreatic Neoplasms 36 Carcinoma, Non-Small-Cell Lung 30 Esophageal Neoplasms 24 Stomach Neoplasms 19 Neoplasms 17 Esophageal Squamous Cell Carcinoma 14 Adenocarcinoma Of Esophagus 12 Colorectal Cancer Metastatic 11 Lung Neoplasms 9 Head and Neck Neoplasms 8 Breast Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 7 Ovarian Neoplasms 6 Gastrointestinal Neoplasms 6 Endometrial Neoplasms 5 Anus Neoplasms 5 Triple Negative Breast Neoplasms 4 Recurrence 4 Hereditary Sensory and Autonomic Neuropathies 4 Cholangiocarcinoma 4 Carcinoma, Renal Cell 4 Carcinoma, Hepatocellular 4 Advanced Colorectal Cancer 4 Liver Neoplasms 3 Digestive System Neoplasms 3 Carcinoma, Squamous Cell 3

Interventions

Chemoradiotherapy 2 Radiation 1 Paclitaxel 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Colony-Stimulating Factors 1 Cetuximab 1 Carboplatin 1 Adjuvants, Immunologic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00827671 2018-03-09

TRACC

UMC Utrecht

Phase 2 Terminated

Gastrointestinal

Resectable Esophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡